COMPASS MINERALS INTERNATIONAL INC (CMP) stock intrinsic value fair value estimate & owner earnings analysis

Compass Minerals is a global producer of essential minerals built around two businesses: a Salt segment (about 82% of sales) that mines and sells rock salt for winter highway de-icing and for consumer and industrial use, and a smaller Plant Nutrition segment that produces sulfate of potash (SOP), a specialty fertilizer, at its Ogden, Utah facility. The Salt segment runs on some of the largest, lowest-cost underground rock salt mines in the world -- including the largest in Goderich, Ontario -- with a deep-water port that gives it a logistics edge delivering salt across North America and the UK. Demand for highway de-icing salt depends on winter weather rather than the broader economy, which makes it a durable, if lumpy, source of cash flow. Over the past several years the company made two significant bets outside this core business that did not pay off. It spent heavily developing a lithium extraction project at its Ogden site, then terminated it in January 2024 after a Utah regulatory change and worsening lithium economics made the returns unattractive; the associated assets were written down by roughly $92 million combined over fiscal 2024 and 2025. It also acquired a fire-retardant business, Fortress North America, in 2021, and exited it in May 2025 at a loss -- a venture that, as disclosed in the company's fiscal 2025 10-K, is the subject of shareholder lawsuits alleging the company made misleading statements about it. Both distractions are now behind the company, and management has cut corporate overhead (from 12.3% to 9.1% of sales in fiscal 2025) and cut capital spending sharply, from $154 million in fiscal 2023 to $70 million in fiscal 2025, as those projects wound down. The company also carries meaningful debt: $650 million of 8% senior notes issued in June 2025 and maturing in 2030, used to refinance an earlier, more expensive bond and its revolving credit facility. That's a high coupon, and servicing it consumes a large share of the cash the business generates before any reaches shareholders; the quarterly dividend was cut roughly in half during fiscal 2025. We measure the cash the business actually generates for owners after real maintenance spending, stripping out swings from inventory and receivables timing and non-cash items like the impairments above. Over the four most recent fiscal years (2022-2025) that figure has been volatile and, on a normalized basis, modest: roughly $0.42 per share in a typical year, based on the two cleanest recent years (fiscal 2022 and fiscal 2025) together with a genuinely weak fiscal 2024. We set fiscal 2023 aside when picking this normal level because that year's heavy capital spending was distorted by the now-abandoned lithium project and by a one-time investment gain, not by the ongoing business; fiscal 2024 stays in the mix because it's real information about how rough a bad year here can look. Base case: the Salt business continues on its current path -- modest volume growth with periodic price resets through its municipal and state supply contracts -- while capital spending stays in the lower, post-lithium/post-Fortress range of roughly $60-80 million a year, and Plant Nutrition neither improves much nor deteriorates further. Starting from the ~$0.42/share normalized level, we assume modest single-digit annual growth through the ten-year forecast, tapering to a flat, no-growth continuation after that -- reflecting a Salt franchise whose mine reserves support operation for decades, but with no further identified driver of growth once today's visible cost and pricing initiatives are captured. On this path the shares are worth roughly $8 today. Bear case: this reflects the company's demonstrated fragility -- leverage that leaves little room for a mild winter or continued softness in sulfate-of-potash pricing (which already triggered a goodwill impairment in Plant Nutrition), plus a recent track record of capital misallocation worth weighing even though both misadventures are now behind the company. Owner earnings stay thin and roughly flat near the weak end of the recent range, and we assume no value survives past the 2030 maturity of the senior notes, since a decade of thin cash flow against that debt wall could force a refinancing on worse terms or a dilutive equity raise. That produces a bear value of under $1 per share. Bull case: if Salt pricing holds up, Plant Nutrition stabilizes rather than erodes further, and the capital discipline shown in fiscal 2025 continues -- with debt gradually paid down using the resulting free cash flow -- earnings power could grow at a high-single-digit pace for several years before settling into the same structurally supported continuation value as the base case. That path is worth roughly $13 per share. Given the leverage, the commodity-price exposure in Plant Nutrition, and the still-fresh history of value-destroying side bets, the margin-of-safety price sits at a meaningful discount to the base case and assumes confirmation that Plant Nutrition has stopped requiring further write-downs and that capital spending has genuinely settled into its lower range. What could make this wrong: a handful of smaller non-cash reconciling items (foreign-exchange remeasurement, contingent-consideration fair-value adjustments) were not individually traced in every year, though total cash generated and the working-capital swings were checked directly against the filed cash-flow statements, and the most recent fiscal year's figures were reconciled exactly.